Tag: Prescription Drugs
Lopinavir-Ritonavir No Benefit in Adults With Severe COVID-19
No benefit seen in time to clinical improvement, mortality at 28 days compared with standard care alone
Statement Addresses Concerns About Heart Meds and COVID-19
Patients advised to continue ACE inhibitors/ARBs after researcher posits risk for severe COVID-19 infection
Metformin Could Reduce Obesity in Children
Metformin therapy reduces some indices of obesity in children and adolescents, review shows
Chinese Researchers Say Flu Drug Effective Against COVID-19
Scientists believe that favipiravir blocks the coronavirus from replicating in the body
Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
Low-certainty evidence showed inconclusive effects for all-cause mortality, cardiovascular mortality, MI
New HIV PrEP Drug Not Cost-Effective Compared With Generic
F/TAF would avert 2,101 fractures, 25 cases of end-stage renal disease, but not deemed cost-effective
Romosozumab Added to Guideline for Management of Osteoporosis
Drug recommended for postmenopausal women at very high fracture risk but not at high risk for heart disease, stroke
Anticholinergic Burden Tied to Adverse Effects in Middle Age
Identification of at-risk populations varies by scale used, which could impact clinical practice
Gabapentin Seems Efficacious for Alcohol Use Disorder
Positive effect seen on heavy drinking days, total abstinence, especially in high alcohol withdrawal group
Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
T2DM risk reduced by 39 percent for those with high adherence to antimalarial therapy for managing lupus
